Annual Current Liabilities
$24.91 M
-$7.33 M-22.74%
31 December 2023
Summary:
Adverum Biotechnologies annual total current liabilities is currently $24.91 million, with the most recent change of -$7.33 million (-22.74%) on 31 December 2023. During the last 3 years, it has risen by +$4.04 million (+19.37%). ADVM annual current liabilities is now -22.74% below its all-time high of $32.25 million, reached on 31 December 2022.ADVM Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Liabilities
$27.66 M
+$5.20 M+23.13%
30 September 2024
Summary:
Adverum Biotechnologies quarterly total current liabilities is currently $27.66 million, with the most recent change of +$5.20 million (+23.13%) on 30 September 2024. Over the past year, it has dropped by -$1.20 million (-4.16%). ADVM quarterly current liabilities is now -40.49% below its all-time high of $46.47 million, reached on 31 March 2023.ADVM Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ADVM Current Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -22.7% | -4.2% |
| 3 y3 years | +19.4% | +9.2% |
| 5 y5 years | +132.4% | +55.9% |
ADVM Current Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -22.7% | +19.4% | -40.5% | +29.7% |
| 5 y | 5 years | -22.7% | +132.4% | -40.5% | +71.7% |
| alltime | all time | -22.7% | +2869.5% | -40.5% | +2280.1% |
Adverum Biotechnologies Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $27.66 M(+23.1%) |
| June 2024 | - | $22.46 M(+4.2%) |
| Mar 2024 | - | $21.55 M(-13.5%) |
| Dec 2023 | $24.91 M(-22.7%) | $24.91 M(-13.7%) |
| Sept 2023 | - | $28.86 M(-35.2%) |
| June 2023 | - | $44.52 M(-4.2%) |
| Mar 2023 | - | $46.47 M(+44.1%) |
| Dec 2022 | $32.25 M(+51.2%) | $32.25 M(+12.7%) |
| Sept 2022 | - | $28.62 M(-6.5%) |
| June 2022 | - | $30.62 M(+31.8%) |
| Mar 2022 | - | $23.24 M(+9.0%) |
| Dec 2021 | $21.32 M(+2.2%) | $21.32 M(-15.8%) |
| Sept 2021 | - | $25.33 M(+23.4%) |
| June 2021 | - | $20.53 M(+3.0%) |
| Mar 2021 | - | $19.92 M(-4.5%) |
| Dec 2020 | $20.87 M(+7.5%) | $20.87 M(+29.5%) |
| Sept 2020 | - | $16.11 M(-24.2%) |
| June 2020 | - | $21.25 M(+26.8%) |
| Mar 2020 | - | $16.77 M(-13.6%) |
| Dec 2019 | $19.41 M | $19.41 M(+9.4%) |
| Sept 2019 | - | $17.75 M(+74.9%) |
| June 2019 | - | $10.15 M(-4.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $10.61 M(-1.0%) |
| Dec 2018 | $10.72 M(+0.4%) | $10.72 M(+6.5%) |
| Sept 2018 | - | $10.06 M(-11.5%) |
| June 2018 | - | $11.37 M(+22.6%) |
| Mar 2018 | - | $9.27 M(-13.1%) |
| Dec 2017 | $10.67 M(+7.9%) | $10.67 M(+11.0%) |
| Sept 2017 | - | $9.61 M(+15.6%) |
| June 2017 | - | $8.31 M(-30.5%) |
| Mar 2017 | - | $11.97 M(+20.9%) |
| Dec 2016 | $9.90 M(+50.5%) | $9.90 M(-7.1%) |
| Sept 2016 | - | $10.65 M(+34.8%) |
| June 2016 | - | $7.90 M(+42.1%) |
| Mar 2016 | - | $5.56 M(-15.5%) |
| Dec 2015 | $6.57 M(+20.2%) | $6.57 M(+1.2%) |
| Sept 2015 | - | $6.50 M(-17.4%) |
| June 2015 | - | $7.86 M(+3.1%) |
| Mar 2015 | - | $7.63 M(+39.4%) |
| Dec 2014 | $5.47 M(+370.8%) | $5.47 M(+22.6%) |
| Sept 2014 | - | $4.46 M(+11.8%) |
| June 2014 | - | $3.99 M(+148.2%) |
| Mar 2014 | - | $1.61 M(+38.4%) |
| Dec 2013 | $1.16 M(+38.5%) | $1.16 M |
| Dec 2012 | $839.00 K | - |
FAQ
- What is Adverum Biotechnologies annual total current liabilities?
- What is the all time high annual current liabilities for Adverum Biotechnologies?
- What is Adverum Biotechnologies annual current liabilities year-on-year change?
- What is Adverum Biotechnologies quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Adverum Biotechnologies?
- What is Adverum Biotechnologies quarterly current liabilities year-on-year change?
What is Adverum Biotechnologies annual total current liabilities?
The current annual current liabilities of ADVM is $24.91 M
What is the all time high annual current liabilities for Adverum Biotechnologies?
Adverum Biotechnologies all-time high annual total current liabilities is $32.25 M
What is Adverum Biotechnologies annual current liabilities year-on-year change?
Over the past year, ADVM annual total current liabilities has changed by -$7.33 M (-22.74%)
What is Adverum Biotechnologies quarterly total current liabilities?
The current quarterly current liabilities of ADVM is $27.66 M
What is the all time high quarterly current liabilities for Adverum Biotechnologies?
Adverum Biotechnologies all-time high quarterly total current liabilities is $46.47 M
What is Adverum Biotechnologies quarterly current liabilities year-on-year change?
Over the past year, ADVM quarterly total current liabilities has changed by -$1.20 M (-4.16%)